Atlas Trials

This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 Cream

Clinical trial NCT03802344 · COMPLETED

Trial details

NCT number
NCT03802344
Sponsor
MC2 Therapeutics
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Psoriasis Vulgaris
Start date
2018-12-12
Primary completion
2019-10-02
Enrollment
498

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.